FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.9.0  |  FHIR Version n/a  User: [n/a]

929360081000036101: Medicinal product pack reference set (foundation metadata concept)

Status: current, Primitive. Date: 31-Mar 2011. Module: Australian Medicines Terminology module

Descriptions:

Id Description Lang Type Status Case? Module
3288201000168119 MPP (medicinal product pack) reference set en Synonym Active Case sensitive Australian Medicines Terminology module
965507131000036117 Medicinal product pack reference set en Synonym Active Case sensitive Australian Medicines Terminology module
965507141000036110 Medicinal product pack reference set (foundation metadata concept) en Fully specified name Active Case sensitive Australian Medicines Terminology module
4351131000168114 <p>Terminology to describe in a health record an abstract concept representing the properties of one or more quantitatively and clinically equivalent Trade Product Packs.</p><p>This reference set supports the accurate and unambiguous electronic communication and exchange of medicines information between clinicians for medication management and the recording of adverse reactions.</p><p><b>Target client: </b>NCTS</p> en Definition Active Case sensitive Australian Medicines Terminology module

15976 members. Search Members:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Medicinal product pack reference set Has licence SNOMED CT-AU licence​ true Inferred relationship Some 1740441059
Medicinal product pack reference set Developed by Australian Digital Health Agency true Inferred relationship Some 991480534
Medicinal product pack reference set Is a Simple type reference set true Inferred relationship Some
Members
everolimus 2.5 mg tablet, 10
everolimus 2.5 mg tablet, 30
everolimus 2.5 mg tablet, 50
everolimus 2.5 mg tablet, 60
everolimus 2.5 mg tablet, 90
everolimus 250 microgram dispersible tablet, 100
everolimus 250 microgram dispersible tablet, 120
everolimus 250 microgram dispersible tablet, 50
everolimus 250 microgram dispersible tablet, 60
everolimus 250 microgram tablet, 120
everolimus 250 microgram tablet, 60
everolimus 3 mg dispersible tablet, 100
everolimus 3 mg dispersible tablet, 120
everolimus 3 mg dispersible tablet, 30
everolimus 3 mg dispersible tablet, 50
everolimus 3 mg dispersible tablet, 60
everolimus 5 mg dispersible tablet, 100
everolimus 5 mg dispersible tablet, 120
everolimus 5 mg dispersible tablet, 30
everolimus 5 mg dispersible tablet, 50
everolimus 5 mg dispersible tablet, 60
everolimus 5 mg tablet, 10
everolimus 5 mg tablet, 100
everolimus 5 mg tablet, 120
everolimus 5 mg tablet, 30
everolimus 5 mg tablet, 50 tablets (medicinal product pack)
everolimus 5 mg tablet, 60
everolimus 5 mg tablet, 90
everolimus 500 microgram tablet, 120
everolimus 500 microgram tablet, 60
everolimus 7.5 mg tablet, 10
everolimus 7.5 mg tablet, 30
everolimus 7.5 mg tablet, 50
everolimus 7.5 mg tablet, 60
everolimus 7.5 mg tablet, 90
everolimus 750 microgram tablet, 120
everolimus 750 microgram tablet, 60
evolocumab 140 mg/mL injection, 1 mL pen device
evolocumab 140 mg/mL injection, 1 mL syringe
evolocumab 140 mg/mL injection, 2 x 1 mL pen devices
evolocumab 140 mg/mL injection, 3 x 1 mL pen devices
evolocumab 420 mg/3.5 mL injection, 3.5 mL cartridge
exametazime 500 microgram injection, 2 vials
exametazime 500 microgram injection, 5 vials
exemestane 25 mg tablet, 15
exemestane 25 mg tablet, 30
exemestane 25 mg tablet, 90
exenatide 10 microgram/0.04 mL injection, 2.4 mL pen device
exenatide 2 mg/0.85 mL modified release injection, 2 mL pen device
exenatide 2 mg/0.85 mL modified release injection, 4 x 2 mL pen devices
exenatide 2 mg modified release injection [1 chamber] (&) inert substance diluent [1 chamber], 1 dual chamber pen device
exenatide 2 mg modified release injection [1 chamber] (&) inert substance diluent [1 chamber], 4 dual chamber pen devices
exenatide 2 mg modified release injection [1 vial] (&) inert substance diluent [1 syringe], 1 pack
exenatide 2 mg modified release injection [1 vial] (&) inert substance diluent [1 syringe], 4 x 1 packs
exenatide 5 microgram/0.02 mL injection, 1.2 mL pen device
ezetimibe 10 mg + simvastatin 10 mg tablet, 10
ezetimibe 10 mg + simvastatin 10 mg tablet, 30
ezetimibe 10 mg + simvastatin 10 mg tablet, 5
ezetimibe 10 mg + simvastatin 20 mg tablet, 10
ezetimibe 10 mg + simvastatin 20 mg tablet, 30
ezetimibe 10 mg + simvastatin 20 mg tablet, 5
ezetimibe 10 mg + simvastatin 40 mg tablet, 10
ezetimibe 10 mg + simvastatin 40 mg tablet, 30
ezetimibe 10 mg + simvastatin 40 mg tablet, 5
ezetimibe 10 mg + simvastatin 80 mg tablet, 10
ezetimibe 10 mg + simvastatin 80 mg tablet, 30
ezetimibe 10 mg + simvastatin 80 mg tablet, 5 tablets (medicinal product pack)
ezetimibe 10 mg tablet [10] (&) rosuvastatin 10 mg tablet [10], 20
ezetimibe 10 mg tablet [10] (&) rosuvastatin 20 mg tablet [10], 20
ezetimibe 10 mg tablet [10] (&) rosuvastatin 40 mg tablet [10], 20
ezetimibe 10 mg tablet [10] (&) rosuvastatin 5 mg tablet [10], 20
ezetimibe 10 mg tablet [30] (&) rosuvastatin 10 mg tablet [30], 60
ezetimibe 10 mg tablet [30] (&) rosuvastatin 20 mg tablet [30], 60
ezetimibe 10 mg tablet [30] (&) rosuvastatin 40 mg tablet [30], 60
ezetimibe 10 mg tablet [30] (&) rosuvastatin 5 mg tablet [30], 60
ezetimibe 10 mg tablet, 10
ezetimibe 10 mg tablet, 14 tablets (medicinal product pack)
ezetimibe 10 mg tablet, 15
ezetimibe 10 mg tablet, 30
ezetimibe 10 mg tablet, 5
ezetimibe 10 mg tablet, 7
ezetimibe 10 mg tablet, 90
factor II 200 units + factor VII 100 units + factor IX 200 units + factor X 220 units + protein C 150 units + protein S 120 units injection [1 vial] (&) inert substance diluent [10 mL vial], 1 pack
factor II 400 units + factor VII 200 units + factor IX 400 units + factor X 440 units + protein C 300 units + protein S 240 units injection [1 vial] (&) inert substance diluent [20 mL vial], 1 pack
factor II 500 units + factor IX 500 units + factor X 500 units injection [1 vial] (&) inert substance diluent [20 mL vial], 1 pack
factor II 800 units + factor VII 400 units + factor IX 800 units + factor X 880 units + protein C 600 units + protein S 480 units injection [1 vial] (&) inert substance diluent [40 mL vial], 1 pack
factor IX 1000 units injection [1 vial] (&) inert substance diluent [10 mL vial], 1 pack
factor IX 500 units injection [1 vial] (&) inert substance diluent [10 mL vial], 1 pack
factor IX 500 international units injection [1 x 500 international unit vial] (&) inert substance diluent [1 x 5 mL vial], 1 pack (medicinal product pack)
factor VIII 1000 units + von Willebrand factor 2000 units injection [1 vial] (&) inert substance diluent [10 mL vial], 1 pack
factor VIII 1000 units + von Willebrand factor 2400 units injection [1 vial] (&) inert substance diluent [10 mL vial], 1 pack
factor VIII 1000 international units injection [1 x 1000 international unit vial] (&) inert substance diluent [1 x 10 mL vial], 1 pack (medicinal product pack)
factor VIII 250 units + von Willebrand factor 500 units injection [1 vial] (&) inert substance diluent [5 mL vial], 1 pack
factor VIII 250 units + von Willebrand factor 600 units injection [1 vial] (&) inert substance diluent [5 mL vial], 1 pack
factor VIII 250 units injection [1 vial] (&) inert substance diluent [5 mL vial], 1 pack
factor VIII 500 units + von Willebrand factor 1000 units injection [1 vial] (&) inert substance diluent [10 mL vial], 1 pack
factor VIII 500 units + von Willebrand factor 1000 units injection [1 vial] (&) inert substance diluent [5 mL vial], 1 pack
factor VIII 500 units + von Willebrand factor 1200 units injection [1 vial] (&) inert substance diluent [10 mL vial], 1 pack
factor VIII 500 units + von Willebrand factor 1200 units injection [1 vial] (&) inert substance diluent [5 mL vial], 1 pack
factor VIII 500 units injection [1 vial] (&) inert substance diluent [10 mL vial], 1 pack
factor VIII inhibitor bypassing fraction 1000 units injection [1 vial] (&) inert substance diluent [20 mL vial], 1 pack

Start Previous Page 70 of 160 Next End

Reference Sets

Reference set descriptor

Back to Start